Skip to content
10-Q

Quarterly Report

CervoMed Inc. CRVO

0001437749-25-033879

← back to feed
Filed
Nov 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 5, 2025 9.25M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$16.87M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$8.48M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $9.44M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $9M
Stockholders Equity Q3 2025 · Sep 30, 2025 $26.01M
Stockholders Equity Q3 2025 · Jun 30, 2025 $33.44M
Stockholders Equity Q3 2025 · Dec 31, 2024 $39.2M
Stockholders Equity Q3 2025 · Sep 30, 2024 $45.64M
Stockholders Equity Q3 2025 · Dec 31, 2023 $7.38M
Total Liabilities Q3 2025 · Sep 30, 2025 $4.6M
Total Liabilities Q3 2025 · Dec 31, 2024 $3.88M
Current Assets Q3 2025 · Sep 30, 2025 $30.61M
Current Assets Q3 2025 · Dec 31, 2024 $43.08M
Total Assets Q3 2025 · Sep 30, 2025 $30.61M
Total Assets Q3 2025 · Dec 31, 2024 $43.08M
Eps Basic Q3 2025 · Sep 30, 2025 −$0.84
Eps Basic Q3 2025 · Sep 30, 2025 −$2.10
Eps Basic Q3 2025 · Sep 30, 2024 −$0.55
Eps Basic Q3 2025 · Sep 30, 2024 −$1.22
Sga Expense Q3 2025 · Sep 30, 2025 $2.33M
Sga Expense Q3 2025 · Sep 30, 2025 $7.97M
Sga Expense Q3 2025 · Sep 30, 2024 $2.21M
Sga Expense Q3 2025 · Sep 30, 2024 $6.85M
Rd Expense Q3 2025 · Sep 30, 2025 $6.04M
Rd Expense Q3 2025 · Sep 30, 2025 $15.99M
Rd Expense Q3 2025 · Sep 30, 2024 $5.13M
Rd Expense Q3 2025 · Sep 30, 2024 $11.71M
Net Income Q3 2025 · Sep 30, 2025 −$7.73M
Net Income Q3 2025 · Sep 30, 2025 −$18.88M
Net Income Q3 2025 · Sep 30, 2024 −$4.75M
Net Income Q3 2025 · Sep 30, 2024 −$9.58M
Operating Income Q3 2025 · Sep 30, 2025 −$8.04M
Operating Income Q3 2025 · Sep 30, 2025 −$19.96M
Operating Income Q3 2025 · Sep 30, 2024 −$5.4M
Operating Income Q3 2025 · Sep 30, 2024 −$10.99M
Revenue Q3 2025 · Sep 30, 2025 $322.57K
Revenue Q3 2025 · Sep 30, 2025 $4M
Revenue Q3 2025 · Sep 30, 2024 $1.94M
Revenue Q3 2025 · Sep 30, 2024 $7.58M